Metoprolol

Metoprolol is a beta-adrenergic blocker. The US label read, for Lopressor Oral Solution (metoprolol tartrate, a liquid taken by mouth), says it is indicated in adult patients for hypertension, to lower blood pressure; for the long-term treatment of angina pectoris; and, in hemodynamically stable patients with definite or suspected acute myocardial infarction, to reduce cardiovascular mortality when used alone or in conjunction with intravenous metoprolol.

Also called Lopressor

  • Drug
  • In this atlas

Overview

Technical summary

RxNorm ingredient 6918; UNII W5S57Y3A5L. The label names the substance as metoprolol tartrate, so UNII W5S57Y3A5L is the UNII of the tartrate salt and is a broad match. MeSH descriptor D008790 is Metoprolol. Class: beta-Adrenergic Blocker (FDA established pharmacologic class, RxClass). The label read is the Validus Pharmaceuticals LLC label for LOPRESSOR Oral Solution (metoprolol tartrate), application NDA219373, effective 2025-05-15 in openFDA. Other metoprolol labels in openFDA, including the LOPRESSOR tablet label and extended-release succinate products, were not read. This page records label indications and the class only: no trial result and no dose is given.

Trials at a glance

The figures count the 11 registry trials in this atlas that name this drug or a product that contains it. Trials that use another name for it are not counted.

Trials
11
Phase 3 or 4
9
Recruiting
1
Regulatory decisions
0
Trials by phase (rows) and registry status (columns)
PhaseRecruitingCompletedTerminatedUnknown statusAll statuses
Phase 202002
Phase 311002
Phase 405117
All phases181111

Conditions these trials study

And 1 more.

Sponsors with the most trials

The lead sponsor of each trial, as the registry names it.

And 6 more.

About this drug

Level
Substance
Mechanism
Not reported

Classification codes

  • UNII W5S57Y3A5L

Claims and evidence

Context Adults for whom the US label of metoprolol (Lopressor Oral Solution) lists an indication: hypertension, angina pectoris, definite or suspected acute myocardial infarction

Recipient
Adult
Population
Patients described in the indications section of the label, which says the medicine is indicated in adult patients.
Care setting
Prescription medicine, as described in the US label
Geography
United States (label of the US Food and Drug Administration)
Life stage
Adults, as the passage read states
Follow-up
Not applicable (label statement)
Eligibility: 3 inclusion criteria; exclusion criteria not stated
Included
Excluded
None stated
  • Description Evidence stage not applicable Certainty not assessed

    The US label of LOPRESSOR Oral Solution (metoprolol tartrate), in the Validus Pharmaceuticals LLC version dated 2025-05-15 in openFDA, lists the medicine, in adult patients, for the treatment of hypertension, to lower blood pressure; for the long-term treatment of angina pectoris; and for hemodynamically stable patients with definite or suspected acute myocardial infarction, to reduce cardiovascular mortality when used alone or in conjunction with intravenous metoprolol.

    Applies to Adult Adults for whom the US label of metoprolol (Lopressor Oral Solution) lists an indication: hypertension, angina pectoris, definite or suspected acute myocardial infarction

    Certainty method
    Not assessed
    Limitations
    This claim records what the label says the medicine is indicated for. It is not a finding about how well the medicine works, and no trial result is recorded for it in this atlas. The label may list other indications that were not recorded. Contraindications, doses, interactions and warnings were not read. Labels change, and openFDA also lists other versions with different dates. openFDA's own disclaimer says not to rely on it for decisions about medical care.
    Last checked
    2026-11-08
    Next evidence check due
    Not scheduled
    Sources and citations (2)
    1. Supports openFDA drug label record for LOPRESSOR Oral Solution (metoprolol tartrate), Validus Pharmaceuticals LLC label: indications and substance identifiers

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA drug label record for set id 9f448171-9588-4a54-88b3-5d870060ce86 (LOPRESSOR Oral Solution; manufacturer Validus Pharmaceuticals LLC, application NDA219373), returned on 2026-11-08. The label text is dated 2025-05-15 (effective_time). Other openFDA records of metoprolol labels from other sponsors and repackagers exist and were not used.

      Locator
      results[0].indications_and_usage[0], 1 INDICATIONS AND USAGE
      How it applies
      The label sentences that give the indications named in the statement, each quoted in the research quote table.
      Retrieved
      Source effective date
      2025-05-15
      Source state
      Current
      Version fingerprint
      25523029411d76fb5b7bd58d2ed1c4d5df2146c6fea9ccb8c83dccf569e19758
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-08, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed in the atlas repository.
    2. Background openFDA drug label record for LOPRESSOR Oral Solution (metoprolol tartrate), Validus Pharmaceuticals LLC label: indications and substance identifiers

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA drug label record for set id 9f448171-9588-4a54-88b3-5d870060ce86 (LOPRESSOR Oral Solution; manufacturer Validus Pharmaceuticals LLC, application NDA219373), returned on 2026-11-08. The label text is dated 2025-05-15 (effective_time). Other openFDA records of metoprolol labels from other sponsors and repackagers exist and were not used.

      Locator
      results[0].effective_time
      How it applies
      Effective date of the label text read, 20250515.
      Retrieved
      Source effective date
      2025-05-15
      Source state
      Current
      Version fingerprint
      25523029411d76fb5b7bd58d2ed1c4d5df2146c6fea9ccb8c83dccf569e19758
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-08, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed in the atlas repository.

FDA label

The FDA label of the application holder, as the openFDA label dataset holds it, for the products that contain this drug.

DUTOPROL

No label from the application holder was found in the openFDA label dataset for application NDA021956. This page does not show another labeler's label in its place.

KAPSPARGO SPRINKLE

No label from the application holder was found in the openFDA label dataset for application NDA210428. This page does not show another labeler's label in its place.

LOPRESSOR

No label from the application holder was found in the openFDA label dataset for application NDA017963. This page does not show another labeler's label in its place.

LOPRESSOR

No label from the application holder was found in the openFDA label dataset for application NDA018704. This page does not show another labeler's label in its place.

LOPRESSOR

No label from the application holder was found in the openFDA label dataset for application NDA019786. This page does not show another labeler's label in its place.

LOPRESSOR

No label from the application holder was found in the openFDA label dataset for application NDA218698. This page does not show another labeler's label in its place.

LOPRESSOR

No label from the application holder was found in the openFDA label dataset for application NDA219373. This page does not show another labeler's label in its place.

LOPRESSOR HCT

No label from the application holder was found in the openFDA label dataset for application NDA018303. This page does not show another labeler's label in its place.

TOPROL-XL

No label from the application holder was found in the openFDA label dataset for application NDA019962. This page does not show another labeler's label in its place.

FDA decisions timeline

The regulatory decisions of the FDA that this atlas holds for this drug and the products that contain it, oldest first. Each links to its full record.

  1. Approval NDA017963 LOPRESSOR
  2. Supplemental approval NDA017963 LOPRESSOR
  3. Supplemental approval NDA017963 LOPRESSOR
  4. Approval NDA018704 LOPRESSOR
  5. Approval NDA018303 LOPRESSOR HCT
  6. Supplemental approval NDA017963 LOPRESSOR
  7. Approval NDA019786 LOPRESSOR
  8. Approval NDA019962 TOPROL-XL
  9. Supplemental approval NDA019962 TOPROL-XL
  10. Supplemental approval NDA019962 TOPROL-XL
  11. Approval NDA021956 DUTOPROL
  12. Supplemental approval NDA019962 TOPROL-XL
  13. Approval NDA210428 KAPSPARGO SPRINKLE
  14. Approval NDA219373 LOPRESSOR
  15. Approval NDA218698 LOPRESSOR

Clinical links

Each link reports what one cited claim says about one population. "Evaluated for" means studied, not shown to work. These links do not show that anything is effective or right for you.

Registry records

Assembled by a program from ClinicalTrials.gov and openFDA. No person wrote or checked these pages, and they are counted apart from the pages that people wrote. Lists of trials come from the registry's own coding and may miss trials.

Registry products 9

  • A new drug application (NDA) that FDA lists in Drugs@FDA, with an original approval and 3 efficacy supplement approvals on record.

    ProductNDA017963

  • A new drug application (NDA) that FDA lists in Drugs@FDA, with an original approval and no efficacy supplement approvals on record.

    ProductNDA018303

  • A new drug application (NDA) that FDA lists in Drugs@FDA, with an original approval and no efficacy supplement approvals on record.

    ProductNDA018704

  • A new drug application (NDA) that FDA lists in Drugs@FDA, with an original approval and no efficacy supplement approvals on record.

    ProductNDA019786

  • A new drug application (NDA) that FDA lists in Drugs@FDA, with an original approval and 3 efficacy supplement approvals on record.

    ProductNDA019962

  • A new drug application (NDA) that FDA lists in Drugs@FDA, with an original approval and no efficacy supplement approvals on record.

    ProductNDA021956

  • A new drug application (NDA) that FDA lists in Drugs@FDA, with an original approval and no efficacy supplement approvals on record.

    ProductNDA210428

  • A new drug application (NDA) that FDA lists in Drugs@FDA, with an original approval and no efficacy supplement approvals on record.

    ProductNDA218698

  • A new drug application (NDA) that FDA lists in Drugs@FDA, with an original approval and no efficacy supplement approvals on record.

    ProductNDA219373

Registry trials 11

Record details

Record id
cardio:metoprolol
Content hash
aa8bbf44c67d4e7ce15a63469149fd7e1b5855e3daadaaec1ddf97a3658c76a5